Public Health Resources

FDA Evaluation of Reproductive Therapies Fellowship Organization:  U.S. Food and Drug Administration (FDA) Reference Code: FDA-CDER-2020-0487 A complete application consists of: An application Transcripts – A current resume/CV, including academic history, employment history, relevant experiences, and publication list One educational or professional recommendation.  Your application will be considered incomplete, and will not be reviewed until one recommendation is submitted. All documents must be in English or include an official English translation. If you have questions, send an email to ORISE.FDA.CDER@orau.org. Please include the reference code for this opportunity in your email. Application Deadline 6/30/2020 3:00:00 PM Eastern Time Zone Description Applications will be reviewed on a rolling-basis. A research opportunity is currently available in the Office of Translational Sciences/Office of Biostatistics at the Center for Drug Evaluat...

Calling for innovation related to coronavirus: data, diagnostics, tests, tele-health, or other solutions. Numerous Health Transformers in the StartUp Health community are working tirelessly on COVID-19 solutions that may be able to save lives in this and future outbreaks. Much more innovation is needed, which is why StartUp Health is looking to invest in innovators from around the world working on direct or indirect solutions for mitigating, managing, or treating coronavirus or future pandemics. StartUp Health is launching an open call for innovation as part of our Cure Disease Moonshot and putting the full support of the StartUp Health platform and network behind bringing your innovations to the world. Whether you have technologies that may help speed up the R&D process for finding treatments or you have solutions that can help with diagnostics, home care, hygiene or telemedicine, we want to meet you. This is a broad call for innovations that can aid the public, pati...